Recursion Pharmaceuticals, Inc. announced in February 2024, the company named Kristen Rushton, M.B.A. as Chief Business Operations Officer. Ms. Rushton has worked at the company for over 6 years, previously serving as Senior Vice President of Business Operations. Prior to the company, Ms. Rushton worked at Myriad Genetics and Myrexis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.85 USD | -3.28% |
|
-4.43% | -10.24% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.24% | 2.1B | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals, Inc. Appoints Kristen Rushton as Chief Business Operations Officer